Background: The J20 mouse is an established model of amyloid pathology, exhibiting neuropathological and behavioural symptoms reflective of human Alzheimer's disease (AD). Previous work, conducted by Castanho et al (2020), revealed transcriptomic change in the hippocampus of J20 mice to be associated with the accumulation of amyloid pathology. Here, we investigated the spatial distribution of such transcriptomic changes using novel spatial transcriptomic technology.
Method: 10µm fresh-frozen brain slices were collected from the brains of J20 mice and WT controls. Slices were mounted on 10x genomics visium slides and processed according to the manufacturer recommendations. A total of 47 spatial clusters were identified, 6 of which corresponded to the hippocampus. Differential expression analysis was conducted on the hippocampus and sub-regions of interest (CA1 & CA3 pyramidal cell layers, and dentate gyrus granule cell layer). High dimensional weighted gene co-expression network analysis (hdWGCNA) was conducted to identify spatially-resolves networks of co-expressed genes.
Result: Various differentially expressed genes (DEGs) were identified across the hippocampus of J20 mice compared with WT controls. Many of said DEGs were found to be cluster-specific, indicating transcriptomic change to be specific to hippocampal sub-regions. hdWGCNA modules were also highly region-specific. Many of said genes/hdWGCNA modules, and the associated biological pathways, were associated with AD pathology and behaviour.
Conclusion: Overall, these results demonstrate region-specific transcriptional changes in the hippocampus of J20 mice compared with WT controls. DEGs and networks of co-expressed genes were found to be associated with disease-associated pathways, giving insight into region-specific pathological changes with disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.092346 | DOI Listing |
Alzheimers Dement
December 2024
Institute of Brain Sciene, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Background: Genome-wide association studies demonstrated that immune suppressive receptor CD33 variants are associated with high susceptibility to developing Alzheimer's disease (AD). Human CD33 (hCD33) regulates microglial immune response and clearance ability. However, the differential regulation of phagocytosis by human and mouse CD33 imposes constraints on utilizing the mouse model for investigating the role of CD33 in AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Buenos Aires, Buenos Aires, Argentina.
Background: Alzheimer's disease is characterized by the accumulation of aggregated amyloid peptides in the brain parenchyma and in the walls of brain vessels. The hippocampus - a complex brain structure that plays a key role in learning and memory - has been implicated in the disease. However, there is limited data on vascular changes during the pathological degeneration of Alzheimer's disease in this vulnerable structure, which has distinctive vascular features.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Background: Disrupted balance between amyloidogenic and non-amyloidogenic pathways leads to cognitive decline in Alzheimer's disease (AD). Evidence suggests vitamin A (VA) supplementation favors the non-amyloidogenic pathway through upregulation of α-secretase. Originally used to map embryonic retinoic acid (RA) signaling, RARE-LacZ mice possess multiple LacZ genes controlled by retinoic acid response elements (RAREs).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Exeter, Exeter, United Kingdom.
Background: The J20 mouse is an established model of amyloid pathology, exhibiting neuropathological and behavioural symptoms reflective of human Alzheimer's disease (AD). Previous work, conducted by Castanho et al (2020), revealed transcriptomic change in the hippocampus of J20 mice to be associated with the accumulation of amyloid pathology. Here, we investigated the spatial distribution of such transcriptomic changes using novel spatial transcriptomic technology.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Douglas Research Centre/ McGill University, Montreal, QC, Canada.
Background: Altered neuronal timing and synchrony are biomarkers for Alzheimer's disease (AD) and correlate with memory impairments. Electrical stimulation of the fornix, the main fibre bundle connecting the hippocampus to the septum, has emerged as a potential intervention to restore network synchrony and memory performance in human AD and mouse models. However, electrical stimulation is non-specific and may partially explain why fornix stimulation in AD patients has yielded mixed results.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!